REED ELIZABETH E Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
42
Insider Sells Sum
$2.2M

Insider Activity of REED ELIZABETH E

According to the SEC Form 4 filings, REED ELIZABETH E, being in a position of

  1. Chief Legal Officer and GC at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 163419 shares for $7.02M,
    over all time since 2018-01-05, has bought 0 shares, and sold 276814 shares for $9.47M.

Biography of REED ELIZABETH E

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$7,016,22012100

Comparison of Insiders on Amount of Buys and Sells

2026-09-15SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
37,500
0.0402%
$62.34$2.34M-15.55%
2026-05-06SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
2,076
0.0022%
$43.95$91,240+25.87%
2026-05-05SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
2,174
0.0024%
$46.65$101,417+25.7%
2026-05-04SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
20,000
0.0217%
$45.00$900,000+25.34%
2026-04-15SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
6,785
0.0098%
$41.83$283,810+36.08%
2026-04-14SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
44,715
0.0635%
$41.21$1.84M+31.88%
2026-04-01SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
10,000
0.0104%
$30.00$300,000+75.4%
2026-03-16SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
10,000
0.0109%
$28.09$280,861+90.05%
2026-02-17SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
10,000
0.0108%
$27.83$278,315+78.57%
2026-02-04SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
2,994
0.0034%
$32.18$96,359+59.22%
2026-02-03SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
7,175
0.0078%
$32.12$230,461+53.44%
2026-01-20SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
10,000
0.0109%
$27.34$273,420+76.31%
2025-09-22SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
10,000
0.011%
$25.00$250,000+41.57%
2025-05-05SaleTravere Therapeutics, Inc.
TVTX
Chief Legal Officer and GC
4,920
0.0054%
$21.05$103,566+29.47%
2025-02-12SaleTravere Therapeutics, Inc.
TVTX
SVP, GC & CORPORATE SECRETARY
8,000
0.0091%
$23.53$188,240-9.09%
2025-02-03SaleTravere Therapeutics, Inc.
TVTX
SVP, GC & CORPORATE SECRETARY
8,951
0.0099%
$19.78$177,051+4.3%
2025-01-22SaleTravere Therapeutics, Inc.
TVTX
SVP, GC & CORPORATE SECRETARY
2,437
0.0028%
$19.46$47,424+6.94%
2024-09-09SaleTravere Therapeutics, Inc.
TVTX
SVP, GC & CORPORATE SECRETARY
4,387
0.0051%
$11.52$50,538+37.44%
2024-02-01SaleTravere Therapeutics, Inc.
TVTX
SVP, GC & CORPORATE SECRETARY
4,764
0.0062%
$8.71$41,495+5.29%
2024-01-23SaleTravere Therapeutics, Inc.
TVTX
SVP, GC & CORPORATE SECRETARY
2,062
0.0027%
$8.96$18,476-3.12%
Total: 55
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.